They'll break down the science, share clinical trial updates, and explain what these advances mean for people living with AMD.

Register today and ask your questions live: zurl.co/5PL54

- with Brigitte Arduini, Susan Borden, Dhruv Sareen, Clive Svendsen, Paul Lee, Charles Ryan, Shilpa Kodati, Caroline Nyaiburi, Keith Wolsieffer, Eric Oh, Shuna Park, Glenna Ford, Keith Dionne and Sally Temple

@cellpress.bsky.social

Dr. Rajesh Rao and the terrific team at the University of Michigan Kellogg Eye Center performed each surgery and conducted clinical assessments.

@umich.edu

This first-in-human Phase 1/2a trial led by study PI Jeffrey Stern seeks to evaluate the safety and tolerability of adult RPE stem cell-derived RPE for treatment of dry age-related macular degeneration.

This work was supported by the National Institutes of Health and Luxa Biotechnology.

Full text | zurl.co/4hwI6
@isscr.org
@cellpress.bsky.social

Using cell surface proteins identified with CITE-seq, we describe unique spatial patterns that suggest functional differences for RPE subpopulations.

- with Swapna Nandakumar, Taylor Bertucci, Thomas Kiehl, Steven Lotz, Yue Wang, Jacob Black, Skanda Sai, Jade Kozak, Brigitte Arduini & Sally Temple

Our own Tom Kiehl, Taylor Bertucci and Brigitte Arduini will collaborate with this interdisciplinary team from @albany.edu, AIM Photonics, @binghamtonu.bsky.social, Hudson Valley Community College, and CUNY Bronx Community College.

Many thanks to Brigitte Arduini, Runia Roy, Dylan Murphy, Jade Kozak, Carmen Nazario, Liz Fisher, Susan Goderie, Habiba Khan, Sally Temple and Jeffrey Stern!

#biomanufacturing #CellTherapy